However, to date, no reports have focused on the effect of hesperidin on obese gene product i.e. leptin in comparison to already approved anti-obesity drug in hyperlipidemic and hyperglycemic conditions. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.